Emerging drugs for the treatment of neuromyelitis optica
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Emerging Drugs"
DOI: 10.1080/14728214.2020.1803828
Abstract: ABSTRACT Introduction Evidence-based treatment options for neuromyelitis optica spectrum disorders (NMOSD) patients are beginning to enter the market. Where previously, there was only the exclusive use of empiric and off-label immunosuppressants in this rare and… read more here.
Keywords: treatment neuromyelitis; emerging drugs; treatment; antibody ... See more keywords